M Markman. Show Affiliations »
Abstract
Mesh： See more » Anthraquinones/administration & dosageAntineoplastic Agents/administration & dosageAntineoplastic Agents/adverse effectsAntineoplastic Agents/therapeutic useAntineoplastic Combined Chemotherapy Protocols/administration & dosageAntineoplastic Combined Chemotherapy Protocols/therapeutic useBleomycin/administration & dosageCarboplatinCatheters, IndwellingCisplatin/administration & dosageClinical Trials as TopicCytarabine/administration & dosageDoxorubicin/administration & dosageEtoposide/administration & dosageFluorouracil/administration & dosageHumansImmunotherapyInfusions, Parenteral/methodsMelphalan/administration & dosageMethotrexate/administration & dosageMitomycins/administration & dosageMitoxantroneNeoplasms/drug therapyOrganoplatinum Compounds/administration & dosage
Substances： See more » AnthraquinonesAntineoplastic AgentsMitomycinsOrganoplatinum CompoundsCytarabineBleomycinEtoposideDoxorubicinCarboplatinMitoxantroneCisplatinMelphalanFluorouracilMethotrexate
Year: 1986 PMID： 2427278 DOI： 10.1016/s0147-0272(86)80014-9
Source DB: PubMed Journal: Curr Probl Cancer ISSN： 0147-0272 Impact factor: 3.187